Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
Maruti Suzuki India LtMay 22, 2020
Sun Pharmaceutical IndMay 22, 2020
ACC LtdMay 22, 2020
Shree Cement Ltd.May 22, 2020
Ajanta Pharma Ltd.May 22, 2020

The market showed a small loss Friday, and S&P BSE SENSEX (SENSEX) ended the day at 30673 points, which is a decline of 0.84 percent. For the week as a whole the index showed a loss of 1.4%.

921 shares were up and 1337 were down, while 148 remained unchanged, and there was no trading in 1557 shares.

Total value of the trading volume for shares and primary capital certificates Friday was approximately 21.4 billion.

Mahindra & Mahindra Financial (532720) developed negatively and fell 6.31 percent to a close of 128 rupee. The stock has not closed lower since Jun 2012. Since the sell signal from rectangle formation four days ago, the stock now has lost 7.73 percent.
Bajaj Finance Ltd (500034) lost 4.67 percent to 1896 rupee. The stock has not closed at a lower price since May 2018. This past week the stock has lost as much as 9.13 percent. Nor technically does it look good. The stock has resistance at 2550 rupee.
It was extremely high volume in Lakshmi Machine Works Ltd. (500252). At session end, 64 million rupee worth of shares had been bought and sold in the stock, which equals 80 times mean daily turnover. Lakshmi Machine Works Ltd. (500252) declined slightly 1.14 percent and ended the day at 2460 rupee. This past week the stock has lost as much as 6.40 percent. Nor technically does it look good. The stock is trend wise negative in the medium term and a further decline is indicated.
Vinyl Chemicals (India) Ltd. (524129) gained 15.10 percent to 82.70 rupee. The stock has not closed at a higher price since Apr 2019. This past week the stock has gained as much as 26.16 percent. The volume was also high. At session end it was bought and sold shares for about 13 million rupee in the stock, which equals seven times mean daily turnover. It also looks good technically. The stock is assessed as technically slightly positive for the medium long term.
Alok Industries Ltd. (521070) moved up and ended at 15.31 rupee, which is an increase of 4.93 percent. The stock has now closed up for the 17. day in a row and this past week the stock has gained as much as 27.48 percent. Technically it also looks good. The stock is trend wise positive in the medium term and a further increase is indicated.

National S.E. weakly lower Friday
The market showed a small loss Friday, and Nifty 50 (NIFTY) ended the day at 9039 points, which is a decline of 0.74 percent. The week as a whole showed a loss of 1.1%.

Small gain on US 500 Friday
The market showed a small gain Friday, and S&P 500 (SP500) ended the day at 2955 points, which is an increase of 0.24 percent. The week as a whole showed a gain of 3.2%.

Indices
S&P BSE SENSEX
arrow red   Negative Candidate
S&P BSE SENSEX does not show any clear trend in the medium long term. The price has had a strong fall after the negative signal from rectangle formation at the break down through the support at 37534. The objective at 32832 is now met, but the formation signals further development in the same direction. There is no support in the price chart and further decline is indicated. In case of a positive reaction, the index has resistance at 33700 points. The index is overall assessed as technically negative for the medium long term.
Nifty 50
arrow red   Weak Negative Candidate
Nifty 50 does not show any clear trend in the medium long term. The price has had a strong fall after the negative signal from rectangle formation at the break down through the support at 11056. The objective at 9605 is now met, but the formation signals further development in the same direction. The index has support at points 7600 and resistance at points 9840. The index is overall assessed as technically slightly negative for the medium long term.
S&P 500
arrow green   Positive Candidate
S&P 500 does not show any clear trend in the medium long term. The index has marginally broken up through the resistance at points 2940. An established break predicts a further rise. RSI diverges negatively against the price, which indicates a danger for a reaction down. The index is overall assessed as technically positive for the medium long term.
Today´s Case
Ajanta Pharma Ltd. (532331) Price 1510.30, May 22, 2020
chart
Ajanta Pharma Ltd. is in a rising trend channel in the medium long term. This shows that investors over time have bought the stock at higher prices and indicates good development for the company. The stock has broken a resistance level in the short term and given a positive signal for the short-term trading range. The stock has marginally broken up through the resistance at rupee 1510. An established break predicts a further rise. Positive volume balance, with high volume on days of rising prices and low volume on days of falling prices, strengthens the stock in the short term. The stock is overall assessed as technically positive for the medium long term.
Recommendation: Positive
Latest days indices
AEX1.61%532.82
ATX0.00%3406.09
CAC402.15%4539.91
COMPX0.43%9324.59
DAX2.87%11391
HEX1.04%8879.48
N1001.91%907.89
OMXC25GI1.58%1424.93
OMXSPI2.09%618.07
OSEBX2.12%793.12
PSI200.84%4276.97
TECDAX2.17%3155.21
UKX-0.37%5993.28
EURUSD0.05%108.9636
CL (OIL)-1.98%33.25
Indices Evaluations
 SML
AEXposnegneutral
ATXneutralneutralneutral
CAC40posneutralneutral
COMPXpospospos
DAXposneutralpos
HEXposnegneutral
N100posneutralpos
OMXC25GIpospospos
OMXSPIposneutralpos
OSEBXposnegpos
PSI20posneutralneg
TECDAXposneutralpos
UKXposneutralpos
EURUSDneutralnegpos
CL (OIL)posneutralneg

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
Mumbai S.E. - Medium term
 
      
7% 75% 18%
 277 Buy Candidates
 2958 Neutral
 734 Sell Candidates
Cancel Analysis News
Disclaimer Copyright © 2020 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

[ Back to default newsletter setup ]

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now